Cahill Thomas
Transaction: 06/05/2026
BUY
Change
+75,000
Price
$3.06
Filing
06/08/2026
Type
BUY
Prime Medicine, Inc.
PRME • Biotechnology
$3.70
▼ -0.01 (-0.27%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$655.73M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 23.8%Healthy liquidity · 4.84Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:24 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.70
Change-0.27%
Shares Out177.22M
Market Cap$655.73M
Enterprise Value$673.14M
52W Range2.67 - 6.94
Beta2.27
P/E-3.49
P/S160.99
P/B16.47
P/FCF-4.10
EV/Sales165.27
Price$3.70
Change-0.27%
Shares Out177.22M
Market Cap$655.73M
Enterprise Value$673.14M
52W Range2.67 - 6.94
Beta2.27
P/E-3.49
P/S160.99
P/B16.47
P/FCF-4.10
EV/Sales165.27
EV/EBITDA-3.65
EV/FCF-4.21
Earnings Yield-28.65%
FCF Yield-24.37%
Dividend Yield0.00%
Gross Margin-58.05%
Oper. Margin-44.98%
Profit Margin-43.42%
Debt/Eq0.96
Current Ratio4.84
Quick Ratio4.84
Target$7.50
Target Upside102.70%
Target Median$7.50
Target Range6.00 - 9.00
Volume2.52M
Avg Volume3.19M
EPS Surprise-0.04
Investment DNA
How strong this company looks for long-term investors
46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
69/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
44/100
Why this score▼
Positive revenue growth · 23.8%Healthy liquidity · 4.84Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 10 analyst votes · 2026-09-05
85/100
Bullish
Bullish
7
Hold
3
Bearish
0
Price Target
2026-08-07
Low
$6.00
Mean
$7.00
Median
$7.00
High
$8.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Chung Wendy
Transaction: 06/05/2026
BUY
Change
+75,000
Price
$3.06
Filing
06/08/2026
Type
BUY
Foster-Cheek Kaye I
Transaction: 06/05/2026
BUY
Change
+75,000
Price
$3.06
Filing
06/08/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Cahill Thomas | BUY | +75,000 | $3.06 | 06/05/2026 | 06/08/2026 |
| Chung Wendy | BUY | +75,000 | $3.06 | 06/05/2026 | 06/08/2026 |
| Foster-Cheek Kaye I | BUY | +75,000 | $3.06 | 06/05/2026 | 06/08/2026 |
| Kelly Michael Aaron | BUY | +75,000 | $3.06 | 06/05/2026 | 06/08/2026 |
| NELSEN ROBERT | BUY | +75,000 | $3.06 | 06/05/2026 | 06/08/2026 |
| Marrazzo Jeffrey D | BUY | +75,000 | $3.06 | 06/05/2026 | 06/08/2026 |
| Schenkein David P | BUY | +75,000 | $3.06 | 06/05/2026 | 06/08/2026 |
| Makhni Svetlana Ni | OTHER | 0 | Not reported | 04/16/2026 | 04/17/2026 |
| Makhni Svetlana Ni | BUY | +800,000 | $3.67 | 04/16/2026 | 04/17/2026 |
| Reine Allan | BUY | +1,300,000 | $4.38 | 02/26/2026 | 02/27/2026 |
| Alenson Carman | BUY | +140,000 | $3.34 | 02/23/2026 | 02/24/2026 |
| LEE ANN L. | BUY | +375,000 | $3.34 | 02/23/2026 | 02/24/2026 |
| GV 2021 GP, L.L.C. | BUY | +1,500,000 | $3.30 | 08/01/2025 | 08/05/2025 |
| Alenson Carman | SELL | -6,254 | $13.63 | 08/01/2025 | 08/05/2025 |
| Reine Allan | SELL | -850,000 | $6.80 | 08/01/2025 | 08/05/2025 |
| Cahill Thomas | SELL | -45,000 | $7.68 | 08/01/2025 | 08/05/2025 |
| Chung Wendy | SELL | -9,006 | $17.00 | 08/01/2025 | 08/05/2025 |
| Foster-Cheek Kaye I | SELL | -45,000 | $7.68 | 08/01/2025 | 08/05/2025 |
| Kelly Michael Aaron | SELL | -39,062 | $14.83 | 08/01/2025 | 08/05/2025 |
| Marrazzo Jeffrey D | SELL | -92,000 | $14.04 | 08/01/2025 | 08/05/2025 |